MEGAN CHAPMAN: Open Payments
NPI 1285490995 · YUMA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$840 in 30 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $352 · 2025 $840
Food & beverage: $840
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $140 |
| AstraZeneca Pharmaceuticals LP | 7 | $137 |
| Travere Therapeutics, Inc. | 1 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $99 |
| Fresenius USA Marketing, Inc. | 4 | $77 |
| Ardelyx, Inc. | 3 | $76 |
| AKEBIA THERAPEUTICS INC | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Cycle Pharmaceuticals Inc | 1 | $24 |
Products named: SYMPLICITY G3, Filspari, FARXIGA, Kerendia, VELPHORO, IBSRELA, Vafseo, LOKELMA.
Industry payments across AZ — which companies pay providers there.
